Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lymphoma, Large B-Cell, Diffuse × spartalizumab × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Nasopharyngeal Carcinoma 6 Stomach Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Rectal Neoplasms 4 Melanoma 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Recurrence 2 Pancreatic Neoplasms 2 Locally Advanced Rectal Cancer 2 Endometrial Neoplasms 2 Carcinoma, Hepatocellular 2 Triple Negative Breast Neoplasms 1 Solid Tumors 1 Solid Tumor, Adult 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Sarcoma 1 Salivary Gland Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Adenocarcinoma Metastatic 1 Ovarian Neoplasms 1 Neuroblastoma 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1

Interventions

Cyclophosphamide 33 Rituximab 32 Magnetic Resonance Spectroscopy 17 Doxorubicin 17 Prednisone 16 Lenalidomide 16 Specimen Handling 15 polatuzumab vedotin 14 fludarabine 13 Biopsy 11 Vincristine 10 Oxaliplatin 10 Gemcitabine 10 zanubrutinib 9 Etoposide 9 glofitamab 7 axicabtagene ciloleucel 7 Immunotherapy, Adoptive 7 Prednisolone 6 tafasitamab 5 obinutuzumab 5 loncastuximab tesirine 5 fludarabine phosphate 5 acalabrutinib 5 Leukapheresis 5 Injections 5 Ifosfamide 5 tisagenlecleucel 4 orelabrutinib 4 ibrutinib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06758037 2025-03-18

HiR+X

First Affiliated Hospital of Ningbo University

Phase 2 Recruiting

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡